AbbVie
ABBV
ABBV
2,403 hedge funds and large institutions have $121B invested in AbbVie in 2020 Q2 according to their latest regulatory filings, with 262 funds opening new positions, 1,280 increasing their positions, 672 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,403
Holders Change
+183
Holders Change %
+8.24%
% of All Funds
49.39%
Holding in Top 10
197
Holding in Top 10 Change
+47
Holding in Top 10 Change %
+31.33%
% of All Funds
4.05%
New
262
Increased
1,280
Reduced
672
Closed
55
Calls
$1.85B
Puts
$2.12B
Net Calls
-$276M
Net Calls Change
+$74.6M
Top Buyers
| 1 |
BlackRock
New York
|
+$2.16B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.14B |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.13B |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$683M |
| 5 |
JPMorgan Chase & Co
New York
|
+$610M |
Top Sellers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$562M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$357M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$307M |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$294M |
| 5 |
Citigroup
New York
|
-$240M |
